Abstract
a patient with subacute sclerosing panencephalitis (SSPE) was treated by direct administration of Interferon B into the cerebral ventricles. Immediately after the first dose intrathecal synthesis of IgG and the CNS antimeasles antibody titer fell significantly, only to rise again to the pretreatment levels 2 months after discontinuation of treatment. There was no improvement in the patient's clinical status.
| Original language | English |
|---|---|
| Pages (from-to) | 277-281 |
| Number of pages | 5 |
| Journal | Italian Journal of Neurological Sciences |
| Volume | 8 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jun 1987 |
Fingerprint
Keywords
- Interferon B
- intraventricular administration
- SSPE
ASJC Scopus subject areas
- Neuroscience(all)
- Clinical Neurology
Cite this
Intraventricular interferon in a case of subacute sclerosing panencephalitis. / Boiardi, A.; Baldini, S. M.; Sghirlanzoni, A.; Mancuso, R.; Corridori, F.
In: Italian Journal of Neurological Sciences, Vol. 8, No. 3, 06.1987, p. 277-281.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Intraventricular interferon in a case of subacute sclerosing panencephalitis
AU - Boiardi, A.
AU - Baldini, S. M.
AU - Sghirlanzoni, A.
AU - Mancuso, R.
AU - Corridori, F.
PY - 1987/6
Y1 - 1987/6
N2 - a patient with subacute sclerosing panencephalitis (SSPE) was treated by direct administration of Interferon B into the cerebral ventricles. Immediately after the first dose intrathecal synthesis of IgG and the CNS antimeasles antibody titer fell significantly, only to rise again to the pretreatment levels 2 months after discontinuation of treatment. There was no improvement in the patient's clinical status.
AB - a patient with subacute sclerosing panencephalitis (SSPE) was treated by direct administration of Interferon B into the cerebral ventricles. Immediately after the first dose intrathecal synthesis of IgG and the CNS antimeasles antibody titer fell significantly, only to rise again to the pretreatment levels 2 months after discontinuation of treatment. There was no improvement in the patient's clinical status.
KW - Interferon B
KW - intraventricular administration
KW - SSPE
UR - http://www.scopus.com/inward/record.url?scp=0023194965&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023194965&partnerID=8YFLogxK
U2 - 10.1007/BF02337487
DO - 10.1007/BF02337487
M3 - Article
C2 - 2442118
AN - SCOPUS:0023194965
VL - 8
SP - 277
EP - 281
JO - Italian Journal of Neurological Sciences
JF - Italian Journal of Neurological Sciences
SN - 0392-0461
IS - 3
ER -